Stories about Medizin, Gesundheit
- One documentmore
Launch of canSERV Call for Service Provision, "Training the Next Generation of Cancer Researchers"
One documentmore- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
One documentmore - 2
Record financing rounds at the Munich biotech hub
One documentmore - 6
Press Release - hubergroup is Cradle to Cradle certified for the fourth time in a row
One documentmore - 2
PM: DHL Logistics Trend Radar 7.0 beleuchtet neue Entwicklungen in Bereichen wie KI und Nachhaltigkeit / PR: DHL Logistics Trend Radar 7.0 unveils emerging AI trends and sustainable solutions
2 Documentsmore canSERV relaunches Open Call for Service Provision
One documentmorePress release: STADA continues strong growth journey in the first half of 2024
One documentmorecanSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision Open
2 Documentsmore- 4
Sysmex’s PA-100 AST System Wins One of the UK’s Biggest Science Prizes
One documentmore Press release: Alvotech and STADA add to strategic alliance through denosumab partnership
Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...
One documentmorePress release: STADA welcomes CHMP positive opinion on extending indication for Kinpeygo
STADA welcomes CHMP positive opinion on extending indication for Kinpeygo - The CHMP adopted a positive opinion recommending a change to the terms of the marketing authorization of Kinpeygo for the treatment of adults with primary immunoglobulin A, now covering patients with a UPCR of ≥0.8 g/g - ...
One documentmore- 2
PM: IATA CEIV Pharma Certification für DHL Global Forwarding / PR: IATA CEIV Pharma Certification for DHL Global Forwarding
2 Documentsmore Press release: Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK - Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® ...
One documentmorecanSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmore- 3
canSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmore Press release: STADA reduces carbon emissions and increases its renewable energy supply on sustainability journey
STADA reduces carbon emissions and increases its renewable energy supply on sustainability journey - Total carbon emissions by STADA reduced by 25% between 2020 and 2023 - Around 45% of STADA’s electricity consumption now comes from renewable ...
One documentmoreLAST CHANCE: canSERV Second Open Call for Cancer Research Service Provision
One documentmore- 3
canSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer Research
One documentmore Sysmex establishes new branch office in Finland
One documentmorePress release: STADA continues with double-digit sales and profit growth in 2023
One documentmore- 2
PM: DHL Global Forwarding transportiert für kinderherzen die weltweit erste mobile Herzklinik nach El Salvador / PR: DHL Global Forwarding supports NGO kinderherzen to deliver world’s first mobile heart clinic to El Salvador
2 Documentsmore Leipzig Tourismus und Marketing GmbH
5Pioneering Heart Surgery and Medical Congresses in Leipzig
One documentmoreStrengthening the Direct Sales and Service System for Business Expansion in Italy
One documentmorePress release: STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...
One documentmorePress release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner
One documentmorePress release: STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolio
One documentmore- 5
Reflecting on a successful Pharma Forum 2023
One documentmore - 3
EU Provides 1 Mio. to Researchers to Advance Personalised Oncology
One documentmore canSERV Releases Open Call for Transnational Service Provision
One documentmore